Zivo Bioscience Executes Letter Of Intent With Dr. Steven K. Grekin/Grekin Laboratories To Field Exclusive Line Of Beauty-From-Within Nutraceuticals Dec 3, 2018
Zivo Claims Gras Status for its Proprietary Algal Biomass, Allowing Immediate Marketing of its Premiere Product as a Human Food Ingredient Nov 12, 2018
ZIVO Bioscience, Inc. Annual Shareholder Meeting and Conference Call Slated for November 7, 2018 in Detroit, Michigan Oct 30, 2018
Zivo Safety Study Accepted for Publication in Toxicology Journal, Allows Company to Proceed with GRAS Review Panel for Market Approval Sep 20, 2018
Food & Beverage/Consumer Packaged Goods Industry Veteran Joins ZIVO Bioscience, Inc. as VP - Global Operations Jun 21, 2018
Zivo Bioscience, Inc. Reports Positive Results for Synthetic Therapeutic Candidates in a Pilot Experiment as Part of Bovine Mastitis Drug Discovery Program Jun 13, 2018
Largest Shareholder of ZIVO Bioscience, Inc. to extend maturity date of its Convertible Debt Feb 12, 2018
ZIVO Bioscience and Tianjin Norland Biotech Execute Letter of Intent to Produce ZIVO Algae Strain in China for International and Domestic Markets Feb 1, 2018
ZIVO Bioscience Subsidiary Wellmetris Selected to Present at Biotech Showcase During JPMorgan Healthcare Conference Jan 7-10 in San Francisco, CA Jan 8, 2018
